Current concepts: Eating disorders

New England Journal of Medicine

Volumn 340, Issue 14, 1999, Pages 1092-1098

  Becker, Anne E ^a   Grinspoon, Steven K ^a   Klibanski, Anne ^a   Herzog, David B ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Harvard Eating Disorders Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYPROHEPTADINE; DESIPRAMINE; FLUOXETINE; IMIPRAMINE; LEPTIN; NEUROLEPTIC AGENT; ZINC;

AMENORRHEA; ANOREXIA NERVOSA; BINGE EATING DISORDER; BODY WEIGHT; BONE ATROPHY; BULIMIA; EATING DISORDER; ELECTROLYTE DISTURBANCE; ENTERIC FEEDING; EUTHYROID SICK SYNDROME; HEART DISEASE; HUMAN; MEDICAL ASSESSMENT; MORTALITY; NUTRITIONAL DISORDER; NUTRITIONAL STATUS; PARENTERAL NUTRITION; PATIENT EDUCATION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; REVIEW; SOCIAL PSYCHOLOGY; SYMPTOM; FEMALE; MALE; OSTEOLYSIS; PSYCHOLOGICAL ASPECT; REFERENCE VALUE; WEIGHT GAIN;

BODY WEIGHT; BONE RESORPTION; EATING DISORDERS; FEMALE; HUMANS; MALE; NUTRITIONAL STATUS; PSYCHOTHERAPY; REFERENCE VALUES; WEIGHT GAIN;

EID: 0033535479     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199904083401407     Document Type: Review

References (69)

1. Sullivan PF. Mortality in anorexia nervosa. Am J Psychiatry 1995;152: 1073-4.
2. King MB. Eating disorders in a general practice population: prevalence, characteristics and follow-up at 12 to 18 months. Psychol Med Monogr Suppl 1989;14:1-34.
3. Stewart DE, Robinson E, Goldbloom DS, Wright C. Infertility and eating disorders. Am J Obstet Gynecol 1990;163:1196-9.
4. Whitehouse AM, Cooper PJ, Vize CV, Hill C, Vogel L. Prevalence of eating disorders in three Cambridge general practices: hidden and conspicuous morbidity. Br J Gen Pract 1992;42:57-60.
5. Andersen AE. Eating disorders in males. In: Brownell KD, Fairburn CG, eds. Eating disorders and obesity: a comprehensive handbook. New York: Guilford Press, 1995:177-87.
6. Diagnostic and statistical manual of mental disorders, 4th ed.: DSM-IV. Washington, D.C.: American Psychiatric Association, 1994:539-50, 729-31.
7. Hoek HW. The distribution of eating disorders. In: Brownell KD, Fairburn CG, eds. Eating disorders and obesity: a comprehensive handbook. New York: Guilford Press, 1995:207-11.
8. Spitzer RL, Yanovski S, Wadden T, et al. Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 1993;13:137-53.
9. Shisslak CM, Crago M, Estes LS. The spectrum of eating disturbances. Int J Eat Disord 1995;18:209-19.
10. Beck D, Casper R, Andersen A. Truly late onset of eating disorders: a study of 11 cases averaging 60 years of age at presentation. Int J Eat Disord 1996;20:389-95.
11. Bostic JQ, Muriel AC, Hack S, Weinstein S, Herzog D. Anorexia nervosa in a 7 year-old girl. J Dev Behav Pediatr 1997;18:331-3.
12. Crago M, Shisslak CM, Estes LS. Eating disturbances among American minority groups: a review. Int J Eat Disord 1996;19:239-48.
13. Gard MCE, Freeman CP. The dismantling of a myth: a review of eating disorders and socioeconomic status. Int J Eat Disord 1996;20:1-12.
14. Pike KM, Walsh BT. Ethnicity and eating disorders: implications for incidence and treatment. Psychopharmacol Bull 1996;32:265-74.
15. Strober M, Family-genetic studies of eating disorders. J Clin Psychiatry 1991;52:Suppl:9-12.
16. Kendler KS, MacLean C, Neale M, Kessler R, Heath A, Eaves L. The genetic epidemiology of bulimia nervosa. Am J Psychiatry 1991;148:1627-37.
17. Brewerton TD. Toward a unified theory of serotonin dysregulation in eating and related disorders. Psychoneuroendocrinology 1995;20:561-90.
18. Kaye WH, Weltzin TE. Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood. J Clin Psychiatry 1991;52:Suppl:41-8.
19. Bruch H. Eating disorders: obesity, anorexia nervosa, and the person within. New York: Basic Books, 1973.
20. Garner DM, Garfinkel PE, Schwartz D, Thompson M. Cultural expectations of thinness in women. Psychol Rep 1980;47:483-91.
21. Becker AE, Hamburg P. Culture, the media, and eating disorders. Harv Rev Psychiatry 1996;4:163-7.
22. Steinhausen H-C. Treatment and outcome of adolescent anorexia nervosa. Horm Res 1995;43:168-70.
23. Keel PK, Mitchell JE. Outcome in bulimia nervosa. Am J Psychiatry 1997;154:313-21.
24. Cooke RA, Chambers JB Anorexia nervosa and the heart. Br J Hosp Med 1995;54:313-7.
25. Greenfeld D, Mickley D, Quinlan DM, Roloff P. Hypokalemia in outpatients with eating disorders. Am J Psychiatry 1995;152:60-3.
26. Gold PW, Kaye W, Robertson GL, Ebert M. Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa. N Engl J Med 1983;308:1117-23.
27. Devuyst O, Lambert M, Rodhain J, Lefebvre C, Coche E. Haematological changes and infectious complications in anorexia nervosa: a case-control study. QJM 1993;86:791 9.
28. Moshang T Jr, Parks JS, Baker L, et al. Low serum triiodothyronine in patients with anorexia nervosa. J Clin Endocrinol Metab 1975;40:470-3.
29. Biller BMK, Saxe V, Herzog DB, Rosenthal DI, Holzman S, Klibanski A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 1989;68:548-54.
30. Mortola JF, Rasmussen DD, Yen SSC. Alterations of the adrenocorticotropin-cortisol axis in normal weight bulimic women: evidence for a central mechanism. J Clin Endocrinol Metab 1989;68:517-22.
31. Pirke KM, Dogs M, Fichter MM, Tuschl RJ. Gonadotrophins, oestradiol and progesterone during the menstrual cycle in bulimia nervosa. Clin Endocrinol (Oxf) 1988;29:265-70.
32. Andersen AE, Wirth JB, Strahlman ER. Reversible weight related increase in plasma testosterone during treatment of male and female patients with anorexia nervosa. Int J Eat Disord 1982;1(2):74-83.
33. Frisch RE, Revelle R, Cook S. Components of weight at menarche and the initiation of the adolescent growth spurt in girls: estimated total water, lean body weight and fat. Hum Biol 1973;45:469-83.
34. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425 32. [Erratum, Nature 1995;374:479.]
35. Grinspoon S, Gulick T, Askari H, et al. Serum leprin levels in women with anorexia nervosa. J Clin Endocrinol Metab 1996;81:3861-3.
36. Rigotti NA, Nussbaum SR, Herzog DB, Neer RM. Osteoporosis in women with anorexia nervosa. N Engl J Med 1984;311:1601-6.
37. Bachrach LK, Guido D, Katzman D, Litt IF, Marcus R. Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 1990;86: 440-7.
38. Rigotti NA, Neer RM, Jameson L. Osteopenia and bone fractures in a man with anorexia and hypogonadism. JAMA 1986;256:385-8.
39. Herzog W, Minne H, Deter C, et al. Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission. J Bone Miner Res 1993;8:597-605.
40. Rigotti NA, Neer RM, Skates SJ, Herzog DB, Nussbaum SR. The clinical course of osteoporosis in anorexia nervosa: a longitudinal study of cortical bone mass. JAMA 1991;265:1133-8.
41. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 1996;81:3864-70.
42. Herzog DB, Nussbaum KM, Marmor AK. Comorbidity and outcome in eating disorders. Psychiatr Clin North Am 1996;19:843-59.
43. Harris EC, Barraclough B. Suicide as an outcome for mental disorders: a meta-analysis. Br J Psychiatry 1997;170:205-28.
44. Practice guideline for eating disorders. Am J Psychiatry 1993;150:212-28.
45. Mehler PS, Weiner KL. Anorexia nervosa and total patenteral nutrition. Int I Eat Disord 1993;14:297-304.
46. Rigotti NA. Eating disorders. In: Carlson KJ, Eisenstat SA, eds. Primary care of women. St. Louis: Mosby-Year Book, 1995:443-9.
47. Marcus MD. Treatment of obese patients with binge eating disorder. In: Goldstein DJ, ed. The management of eating disorders. Totowa, N.J.: Humana Press (in press).
48. Becker AE, Hamburg P, Herzog DB. The role of psychopharmacologic management in the treatment of eating disorders. In: Dunner DL, Rosenbaum JF, eds. Annual of drug therapy. Philadelphia: W.B. Saunders, 1998:17-51.
49. Klibanski A, Biller BMK, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone Loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995;80:898-904.
50. Franko DL, Walton BE. Pregnancy and eating disorders: a review and clinical implications. Int J Eat Disord 1993;13:41-7.
51. Stewart DE, Raskin J, Garfinkel PE, MacDonald OL, Robinson GE. Anorexia nervosa, bulimia, and pregnancy. Am J Obstet Gynecol 1987; 157:1194-8.
52. Russell GF, Szmukler GI, Dare C, Eisler I. An evaluation of family therapy in anorexia nervosa and bulimia nervosa. Arch Gen Psychiatry 1987;44:1047-56.
53. Bruch H. Anorexia nervosa: therapy and theory. Am J Psychiatry 1982;139:1531-8.
54. Agras WS. Nonpharmacologic treatments of bulimia nervosa. J Clin Psychiatry 1991;52:Suppl:29-33.
55. Fairburn CG, Jones R, Peveler RC, Hope RA, O'Connor M. Psychotherapy and bulimia nervosa: longer-term effects of interpersonal psychotherapy, behavior therapy, and cognitive behavior therapy. Arch Gen Psychiatry 1993;50:419-28.
56. Bruce B, Wilfley D. Binge eating among the overweight population: a serious and prevalent problem. J Am Diet Assoc 1996;96:58-61.
57. Tobin DL. Psychodynamic psychotherapy and binge eating. In: Fairburn CG, Wilson GT, eds. Binge eating: nature, assessment, and treatment. New York: Guilford Press, 1993:287-313.
58. Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. Response to alternative antidepressants in imipramine non-responders with bulimia nervosa. J Clin Psychopharmacol 1989;9:291-3.
59. Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D. Antidepressant treatment of bulimia: a two-year follow-up study. J Clin Psychopharmacol 1985;5:320-7.
60. Wilson GT, Fairburn CG. Cognitive treatments for eating disorders. J Consult Clin Psychol 1993;61:261-9.
61. Jimerson DC, Herzog DB, Brotman AW. Pharmacologic approaches in the treatment of eating disorders. Harv Rev Psychiatry 1993;1:82-93.
62. Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry 1990;47:149-57.
63. Bcumont PJ, Russell JD, Touyz SW, et al. Intensive nutritional counselling in bulimia nervosa: a role for supplementation with fluoxetine? Aust N Z J Psychiatry 1997;31:514-24.
64. Agras WS, Rossiter EM, Arnow B, et al. One-year follow-up of psychosocial and pharmacologic treatments for bulimia nervosa. J Clin Psychiatry 1994;55:179-83.
65. Walsh BT, Wilson GT, Loeb KL, et al. Medication and psychotherapy in the treatment of bulimia nervosa. Am J Psychiatry 1997;154:523-31.
66. Hudson JI, McElroy SL, Raymond NC, et al. Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry 1998;155:1756-62.
67. Gillberg C, Rastam M, Gillberg IC. Anorexia nervosa: who sees the patients and who do the patients see? Acta Paediatr 1994;83:967-71.
68. Bryant-Waugh RJ, Lask BD, Shafran RL, Fosson AR. Do doctors recognise eating disorders in children? Arch Dis Child 1992;67:103-5.
69. Ogg EC, Millar HR, Pusztai EE, Thom AS. General practice consul tation patterns preceding diagnosis of eating disorders. Int J Eat Disord 1997;22:89-93.